SFPQ-ABL1-positive B-cell precursor acute lymphoblastic leukemias

Genes Chromosomes Cancer. 2020 Sep;59(9):540-543. doi: 10.1002/gcc.22852. Epub 2020 Apr 30.

Abstract

In recent years, a subgroup of B-cell precursor acute lymphoblastic leukemia (BCP ALL) without an established abnormality ("B-other") has been shown to be characterized by rearrangements of ABL1, ABL2, CSF1R, or PDGFRB (a.k.a. ABL-class genes). Using FISH with probes for these genes, we screened 55 pediatric and 50 adult B-other cases. Three (6%) of the adult but none of the childhood B-other cases were positive for ABL-class aberrations. RT-PCR and sequencing confirmed a rare SFPQ-ABL1 fusion in one adult B-other case with t(1;9)(p34;q34). Only six SFPQ-ABL1-positive BCP ALLs have been reported, present case included. A review of these shows that all harbored fusions between exon 9 of SFPQ and exon 4 of ABL1, that the fusion is typically found in adolescents/younger adults without hyperleukocytosis, and that IKZF1 deletions are recurrent. The few patients not treated with tyrosine kinase inhibitors (TKIs) and/or allogeneic stem cell transplantation relapsed, strengthening the notion that TKI should be added to the therapy of SFPQ-ABL1-positive BCP ALL.

Keywords: SFPQ-ABL1 fusion; B-cell precursor acute lymphoblastic leukemia; t(1;9)(p34;q34).

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Antineoplastic Agents / therapeutic use
  • Child
  • Child, Preschool
  • Female
  • Humans
  • Ikaros Transcription Factor / genetics
  • Infant
  • Male
  • Oncogene Proteins, Fusion / genetics*
  • PTB-Associated Splicing Factor / genetics*
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / drug therapy
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / genetics*
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / pathology
  • Protein Kinase Inhibitors / therapeutic use
  • Proto-Oncogene Proteins c-abl / genetics*

Substances

  • Antineoplastic Agents
  • IKZF1 protein, human
  • Oncogene Proteins, Fusion
  • PTB-Associated Splicing Factor
  • Protein Kinase Inhibitors
  • Ikaros Transcription Factor
  • ABL1 protein, human
  • Proto-Oncogene Proteins c-abl